MCID: PNL014
MIFTS: 44

Pineal Gland Cancer

Categories: Cancer diseases, Endocrine diseases, Neuronal diseases

Aliases & Classifications for Pineal Gland Cancer

MalaCards integrated aliases for Pineal Gland Cancer:

Name: Pineal Gland Cancer 12 15
Tumor of the Pineal Region 12 74
Pinealoma 12 77
Malignant Neoplasm of Pineal Gland 74
Malignant Tumor of Pineal Gland 12
Malignant Pineal Region Tumor 12
Neoplasm of the Pineal Region 12
Neoplasm of Pineal Gland 12
Pineal Gland Neoplasm 74
Pineal Body Neoplasm 12
Pineocytic Tumor 12
Pineocytoma 74

Classifications:



External Ids:

Disease Ontology 12 DOID:5032
ICD9CM 36 194.4
MeSH 45 D010871
SNOMED-CT 69 47598005 93962006
ICD10 34 C75.3

Summaries for Pineal Gland Cancer

Disease Ontology : 12 An endocrine gland located in the pineal gland located in the brain.

MalaCards based summary : Pineal Gland Cancer, also known as tumor of the pineal region, is related to papillary tumor of the pineal region and pineocytoma. An important gene associated with Pineal Gland Cancer is PTPRS (Protein Tyrosine Phosphatase Receptor Type S), and among its related pathways/superpathways is Neuroscience. The drugs Carboplatin and Melphalan have been mentioned in the context of this disorder. Affiliated tissues include pineal, brain and bone, and related phenotype is nervous system.

Wikipedia : 77 A pinealoma is a tumor of the pineal gland, a part of the brain that produces melatonin. If a pinealoma... more...

Related Diseases for Pineal Gland Cancer

Diseases related to Pineal Gland Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 177)
# Related Disease Score Top Affiliating Genes
1 papillary tumor of the pineal region 34.7 ENO2 SYP
2 pineocytoma 31.1 ASMT ENO2 GFAP SAG SYP
3 pineoblastoma 30.6 ASMT CADPS DICER1 GFAP SAG SYP
4 rhabdoid cancer 30.5 ENO2 SYP
5 atypical teratoid rhabdoid tumor 30.1 GFAP SYP
6 teratoma 29.9 ENO2 GFAP SYP
7 oncocytoma 29.8 KRT18 SYP
8 endodermal sinus tumor 10.4
9 carotid body cancer 10.3 ENO2 SYP
10 malignant sertoli cell tumor 10.3 ENO2 SYP
11 urinary bladder small cell neuroendocrine carcinoma 10.3 ENO2 SYP
12 small cell carcinoma 10.3 ENO2 SYP
13 auditory system cancer 10.3 ENO2 SYP
14 sinonasal undifferentiated carcinoma 10.3 ENO2 SYP
15 pancreatic somatostatinoma 10.3 ENO2 SYP
16 cutaneous ganglioneuroma 10.3 ENO2 SYP
17 extrahepatic bile duct adenocarcinoma 10.3 ENO2 SYP
18 small cell carcinoma of the bladder 10.3 ENO2 SYP
19 sensory organ benign neoplasm 10.3 ENO2 SYP
20 orbital cancer 10.3 ENO2 SYP
21 middle ear adenoma 10.3 ENO2 SYP
22 pulmonary large cell neuroendocrine carcinoma 10.3 ENO2 SYP
23 large cell neuroendocrine carcinoma 10.3 ENO2 SYP
24 gallbladder small cell carcinoma 10.3 ENO2 SYP
25 atypical follicular adenoma 10.3 ENO2 SYP
26 cerebellum cancer 10.3 ENO2 SYP
27 cauda equina neoplasm 10.3 ENO2 SYP
28 endometrial small cell carcinoma 10.3 ENO2 SYP
29 extraosseous chondrosarcoma 10.3 ENO2 SYP
30 malignant teratoma 10.3 ENO2 SYP
31 olfactory nerve neoplasm 10.3 ENO2 SYP
32 autonomic nervous system benign neoplasm 10.3 ENO2 SYP
33 nodular ganglioneuroblastoma 10.3 ENO2 SYP
34 ganglioneuroblastoma 10.3 ENO2 SYP
35 angiomyoma 10.3 ENO2 SYP
36 gastric small cell carcinoma 10.3 ENO2 SYP
37 desmoplastic small round cell tumor 10.3 ENO2 SYP
38 carcinoid tumors, intestinal 10.3 ENO2 SYP
39 respiratory system benign neoplasm 10.3 ENO2 SYP
40 mucinous ovarian cystadenoma 10.3 ENO2 SYP
41 bone benign neoplasm 10.3 ENO2 SYP
42 gastric squamous cell carcinoma 10.3 ENO2 SYP
43 meningeal melanomatosis 10.3 ENO2 SYP
44 extraskeletal ewing sarcoma 10.3 ENO2 SYP
45 male reproductive organ benign neoplasm 10.3 DICER1 SYP
46 connective tissue benign neoplasm 10.3 ENO2 SYP
47 glomus tumor 10.3 ENO2 SYP
48 intraocular retinoblastoma 10.3 ENO2 SYP
49 carcinoid syndrome 10.3 ENO2 SYP
50 cervix small cell carcinoma 10.3 ENO2 SYP

Comorbidity relations with Pineal Gland Cancer via Phenotypic Disease Network (PDN):


Obstructive Hydrocephalus

Graphical network of the top 20 diseases related to Pineal Gland Cancer:



Diseases related to Pineal Gland Cancer

Symptoms & Phenotypes for Pineal Gland Cancer

MGI Mouse Phenotypes related to Pineal Gland Cancer:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.17 CADPS DICER1 ENO2 GFAP PTPRS SAG

Drugs & Therapeutics for Pineal Gland Cancer

Drugs for Pineal Gland Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 188)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 38904 498142
2
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 460612 4053
3
Etoposide Approved Phase 2, Phase 3,Phase 1 33419-42-0 36462
4
Thiotepa Approved, Investigational Phase 2, Phase 3,Phase 1 52-24-4 5453
5
Cyclophosphamide Approved, Investigational Phase 2, Phase 3,Phase 1 50-18-0, 6055-19-2 2907
6
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
7
Sargramostim Approved, Investigational Phase 3,Phase 1 123774-72-1, 83869-56-1
8
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
9
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
10 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
11 Etoposide phosphate Phase 2, Phase 3,Phase 1
12 Adjuvants, Immunologic Phase 3,Phase 1
13 Immunologic Factors Phase 3,Phase 2,Phase 1
14 Narcotics Phase 3
15 Adjuvants, Anesthesia Phase 3
16 Analgesics Phase 3,Phase 2,Phase 1
17 Anesthetics, Intravenous Phase 3
18 Liver Extracts Phase 3,Phase 1,Phase 2
19 Anesthetics, General Phase 3
20 Anesthetics Phase 3
21 Analgesics, Opioid Phase 3
22 Central Nervous System Depressants Phase 3,Phase 2,Early Phase 1
23 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
24 Cola Phase 3,Phase 1
25 Cholinesterase Inhibitors Phase 3,Phase 2
26 Neurotransmitter Agents Phase 3,Phase 2
27 Nootropic Agents Phase 3,Phase 2
28 Cholinergic Agents Phase 3,Phase 2
29
Bevacizumab Approved, Investigational Phase 2 216974-75-3
30
Pregabalin Approved, Illicit, Investigational Phase 2 148553-50-8 5486971
31
Levetiracetam Approved, Investigational Phase 2 102767-28-2 441341
32
Temozolomide Approved, Investigational Phase 1, Phase 2,Phase 2 85622-93-1 5394
33
Irinotecan Approved, Investigational Phase 2,Phase 1 100286-90-6, 97682-44-5 60838
34
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1 22916-47-8 4189
35
Sirolimus Approved, Investigational Phase 2,Phase 1 53123-88-9 46835353 5284616 6436030
36
Everolimus Approved Phase 2,Phase 1 159351-69-6 70789204 6442177
37
Dasatinib Approved, Investigational Phase 2,Phase 1 302962-49-8 3062316
38
Sorbitol Approved Phase 2 50-70-4 5780
39
Titanium dioxide Approved Phase 2 13463-67-7
40
tannic acid Approved Phase 2 1401-55-4
41
Benzocaine Approved, Investigational Phase 2 1994-09-7, 94-09-7 2337
42
Ethanol Approved Phase 2 64-17-5 702
43
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
44
Mechlorethamine Approved, Investigational Phase 1, Phase 2,Phase 2 51-75-2 4033
45
Mannitol Approved, Investigational Phase 1, Phase 2 69-65-8 6251 453
46
Calcium Approved, Nutraceutical Phase 2,Phase 1 7440-70-2 271
47
Vitamin C Approved, Nutraceutical Phase 2 50-81-7 54670067 5785
48
Camptothecin Experimental Phase 1, Phase 2,Phase 2 7689-03-4
49
MK-1775 Investigational Phase 1, Phase 2 955365-80-7, 501-36-0 24856436 445154
50 Dermatologic Agents Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 66)
# Name Status NCT ID Phase Drugs
1 Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors Unknown status NCT00179803 Phase 2, Phase 3
2 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Unknown status NCT01987596 Phase 3
3 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
4 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
5 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
6 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors Completed NCT00025077 Phase 2 carboplatin;cyclophosphamide;thiotepa
7 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
8 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Completed NCT00629889 Phase 2 levetiracetam;pregabalin
9 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
10 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
11 Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma Completed NCT01977677 Phase 1, Phase 2 temozolomide;plerixafor
12 Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma Recruiting NCT02596828 Phase 2 Temozolomide;Irinotecan;Dasatinib;Rapamycin
13 Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Recruiting NCT02095132 Phase 1, Phase 2 Adavosertib;Irinotecan Hydrochloride
14 Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Active, not recruiting NCT01217437 Phase 2 Irinotecan Hydrochloride;Temozolomide
15 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
16 Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Suspended NCT00983398 Phase 1, Phase 2 Carboplatin;Mannitol;Melphalan;Sodium Thiosulfate
17 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
18 Stereotactic Radiosurgery in Treating Patients With Brain Tumors Completed NCT00019578 Phase 1
19 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
20 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
21 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914 Phase 1 temsirolimus
22 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1 bortezomib;temozolomide
23 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
24 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
25 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
26 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel
27 Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Completed NCT01273090 Phase 1 imetelstat sodium
28 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
29 Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors Completed NCT00003484 Phase 1 carmustine;irinotecan hydrochloride
30 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
31 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
32 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
33 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
34 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
35 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
36 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1 cilengitide
37 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
38 SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Recruiting NCT03434262 Phase 1 Gemcitabine;ribociclib;sonidegib;trametinib
39 Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Recruiting NCT02780804 Phase 1 Entinostat
40 EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors Recruiting NCT03638167 Phase 1
41 HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors Recruiting NCT03500991 Phase 1
42 Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Active, not recruiting NCT00867178 Phase 1 Carboplatin;Cisplatin;Cyclophosphamide;Etoposide Phosphate;Isotretinoin;Thiotepa;Vincristine Sulfate;Vorinostat
43 Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Active, not recruiting NCT00638898 Phase 1 busulfan;melphalan;topotecan hydrochloride
44 Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors Terminated NCT00110032 Phase 1 EF5
45 Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Terminated NCT02255461 Phase 1 palbociclib isethionate
46 Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Terminated NCT01088763 Phase 1 gamma-secretase/Notch signalling pathway inhibitor RO4929097;dexamethasone
47 A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Withdrawn NCT01182883 Phase 1 IMC-A12;Temsirolimus
48 Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Unknown status NCT00757614
49 Melatonin Replacement Therapy in Pinealectomized Patients Completed NCT03885258 Early Phase 1 Melatonin Replacement Therapy
50 Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging Completed NCT01884194

Search NIH Clinical Center for Pineal Gland Cancer

Genetic Tests for Pineal Gland Cancer

Anatomical Context for Pineal Gland Cancer

MalaCards organs/tissues related to Pineal Gland Cancer:

42
Pineal, Brain, Bone, T Cells, Ovary, Spinal Cord, Bone Marrow

The Foundational Model of Anatomy Ontology organs/tissues related to Pineal Gland Cancer:

20
The Pineal Gl

Publications for Pineal Gland Cancer

Articles related to Pineal Gland Cancer:

(show top 50) (show all 76)
# Title Authors Year
1
Papillary tumor of the pineal region: Case report and review of the literature. ( 29691144 )
2019
2
Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region. ( 30295836 )
2019
3
Papillary Tumor of the Pineal Region: Systematic Review and Analysis of Prognostic Factors. ( 30989225 )
2019
4
Unedited microneurosurgery of a mixed germ cell tumor of the pineal region. ( 30687573 )
2018
5
Papillary Tumor of the Pineal Region in Children: Presentation of a Case and Comprehensive Literature Review. ( 29906576 )
2018
6
Papillary tumor of the pineal region accompanied by Parinaud's syndrome: magnetic resonance imaging findings. ( 29991845 )
2018
7
Recurrent Pineocytomalike Papillary Tumor of The Pineal Region: A Case Report and Literature Review. ( 30165231 )
2018
8
Unedited microneurosurgery of a large recurrent papillary tumor of the pineal region. ( 30595955 )
2018
9
Masson's tumor of the pineal region: case report. ( 28777021 )
2018
10
A Case of Nongerminomatous Germ Cell Tumor of the Pineal Region: Risks and Advantages of Biopsy by Endoscopic Approach. ( 29713348 )
2018
11
Unedited microneurosurgery of a solitary fibrous tumor of the pineal region. ( 30595953 )
2018
12
Atypical Teratoid/Rhabdoid Tumor of the Pineal Region in a Young Adult Male Patient: Case Report and Review of the Literature. ( 27144539 )
2017
13
Nuclear CRX and FOXJ1 Expression Differentiates Non-Germ Cell Pineal Region Tumors and Supports the Ependymal Differentiation of Papillary Tumor of the Pineal Region. ( 28719464 )
2017
14
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity. ( 26113311 )
2016
15
Increased VEGF levels in one case of papillary tumor of the pineal region with intracranial haemorrhage at presentation: a potential surrogate indicator of tumor angiogenesis and aggressiveness? ( 26745494 )
2016
16
Late dissemination via cerebrospinal fluid of papillary tumor of the pineal region: a case report and literature review. ( 27179224 )
2016
17
A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature. ( 27472995 )
2016
18
Cytologic features of papillary tumor of the pineal region: A case report showing tigroid background. ( 27535020 )
2016
19
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case report. ( 27568037 )
2016
20
Papillary tumor of the pineal region: Histopathological characterization and review of the literature. ( 24556386 )
2015
21
Papillary Tumor of the Pineal Region: MR Signal Intensity Correlated to Histopathology. ( 25688307 )
2015
22
Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. ( 25749579 )
2015
23
Papillary tumor of the pineal region with synchronous suprasellar focus and novel cytogenetic features. ( 26068071 )
2015
24
Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region. ( 26125673 )
2015
25
Papillary tumor of the pineal region presenting with Foster Kennedy sign. ( 26183673 )
2015
26
Papillary tumor of the pineal region-report of three cases with literature review. ( 26238893 )
2015
27
Papillary tumor of the pineal region with extended clinical and radiologic follow-up. ( 26539320 )
2015
28
Papillary tumor of the pineal region: A case report and review of the literature. ( 26622493 )
2015
29
Papillary tumor of the pineal region. Report of two cases and literature review. ( 25440015 )
2014
30
Papillary tumor of the pineal region: a case involving isocitrate dehydrogenase (IDH) genotyping. ( 22466620 )
2013
31
Stereotactic radiosurgery of a papillary tumor of the pineal region: case report and review of the literature. ( 23446182 )
2013
32
Papillary tumor of the pineal region with anaplastic small cell component. ( 23817812 )
2013
33
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report. ( 24019784 )
2013
34
Complete regression of papillary tumor of the pineal region after radiation therapy: case report and review of the literature. ( 22086239 )
2012
35
Four-year clinical and neuroradiological follow-up of a papillary tumor of the pineal region. ( 22124853 )
2012
36
Papillary tumor of the pineal region. ( 22275792 )
2012
37
Papillary tumor of the pineal region: ultrastructural study of a case. ( 22292738 )
2012
38
Early treatment response of a rare papillary tumor of the pineal region after primary proton-beam therapy using the raster-scanning technique at HIT. ( 23235766 )
2012
39
Spinal metastasis of papillary tumor of the pineal region. ( 21109346 )
2011
40
Papillary tumor of the pineal region in a 15-month-old boy. ( 21529195 )
2011
41
Papillary tumor of the pineal region. ( 21629978 )
2011
42
Adjuvant temozolomide chemotherapy for treatment of papillary tumor of the pineal region. ( 21839968 )
2011
43
Papillary tumor of the pineal region: two case studies and a review of the literature. ( 21844577 )
2011
44
Atypical teratoid/rhabdoid tumor of the pineal region in an adult. ( 19911885 )
2010
45
Natural history of papillary tumor of the pineal region: new insights on biological explanation. ( 20454919 )
2010
46
Papillary tumor of the pineal region: report of a rapidly progressive tumor with possible multicentric origin. ( 19037636 )
2009
47
Neuroradiological follow-up of the growth of papillary tumor of the pineal region: a case report. ( 19517065 )
2009
48
Papillary tumor of the pineal region--a recently described entity: a report of three cases and review of the literature. ( 19642509 )
2009
49
Papillary tumor of the pineal region. ( 19667327 )
2009
50
Successful treatment of neoadjuvant therapy for papillary tumor of the pineal region. ( 19856218 )
2009

Variations for Pineal Gland Cancer

Expression for Pineal Gland Cancer

Search GEO for disease gene expression data for Pineal Gland Cancer.

Pathways for Pineal Gland Cancer

Pathways related to Pineal Gland Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.46 ENO2 GFAP SAG SYP

GO Terms for Pineal Gland Cancer

Cellular components related to Pineal Gland Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 photoreceptor inner segment GO:0001917 8.96 ENO2 SAG
2 integral component of synaptic vesicle membrane GO:0030285 8.62 PTPRS SYP

Sources for Pineal Gland Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....